Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

Clinical trial NCT00763932 · COMPLETED

Trial details

NCT number: NCT00763932
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pompe Disease Infantile-Onset Glycogen Storage Disease Type II

Start date: 2003-04-01
Primary completion: 2006-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.